首页> 外文期刊>Prostate Cancer and Prostatic Diseases >miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
【24h】

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

机译:miR-148a是雄激素反应性微RNA,通过抑制其靶CAND1表达来促进LNCaP前列腺细胞的生长

获取原文
       

摘要

Recent advances in cancer biology reveal that microRNAs (miRNAs) are involved in the regulation of cancer-related genes, or they function as tumor suppressors or oncogenes. In prostate cancer, evidence has accumulated for the contribution of the androgen-dependent gene network to tumor growth, although the precise functions of miRNAs in prostate cancer remain to be investigated. Here, we identified androgen-responsive miRNAs by the short RNA sequencing analysis in LNCaP prostate cancer cells. Among 10 miRNAs with known sequences, we have determined that miR-148a reduces the expression of cullin-associated and neddylation-dissociated 1 (CAND1), a negative regulator of SKP1-Cullin1-F-box (SCF) ubiquitin ligases, by binding to the 3′-untranslated region of CAND1 mRNA. CAND1 knockdown by small interfering RNA promoted the proliferation of LNCaP cells. Our study indicates the potential contribution of miR-148a to the growth of human prostate cancer.
机译:癌症生物学的最新进展表明,microRNA(miRNA)参与了与癌症相关的基因的调控,或者它们起着抑癌或癌基因的作用。在前列腺癌中,已经积累了雄激素依赖性基因网络对肿瘤生长的贡献的证据,尽管miRNA在前列腺癌中的确切功能仍有待研究。在这里,我们通过LNCaP前列腺癌细胞中的短RNA测序分析鉴定了雄激素响应性miRNA。在具有已知序列的10个miRNA中,我们已经确定miR-148a通过结合到CAND1 mRNA的3'非翻译区。小干扰RNA对CAND1的抑制作用促进了LNCaP细胞的增殖。我们的研究表明miR-148a对人类前列腺癌生长的潜在贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号